Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)

✍ Scribed by Takada, M.; Ishiguro, H.; Nagai, S.; Ohtani, S.; Kawabata, H.; Yanagita, Y.; Hozumi, Y.; Shimizu, C.; Takao, S.; Sato, N.; Kosaka, Y.; Sagara, Y.; Iwata, H.; Ohno, S.; Kuroi, K.; Masuda, N.; Yamashiro, H.; Sugimoto, M.; Kondo, M.; Naito, Y.; Sasano, H.; Inamoto, T.; Morita, S.; Toi, M.

• Book ID: 125356785
• Publisher: Springer US
• Year: 2014
• Tongue: English
• Weight: 638 KB
• Volume: 145
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-014-2907-9